Transformed Recurrent Non-Hodgkin Lymphoma
5 clinical trials · Condition
◉ Watch Transformed Recurrent Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma (NCT03147885) | Barbara Ann Karmanos Cancer Institute | 2017-06-20 |
| Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT02992522) | Beth Christian | 2017-02-21 |
| Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715) | Mayo Clinic | 2016-01-19 |
| Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma (NCT02051257) | City of Hope Medical Center | 2014-06-19 |
| Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT01719250) | Mayo Clinic | 2012-12-01 |
Track Transformed Recurrent Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.